Caribou Biosciences has launched a Phase 1 trial testing its CAR T-cell therapy CB-010 for lupus affecting the kidneys and ...

A new type of cell-based immunotherapy shows promise for B-cell lymphomas and - due to innovations in manufacturing - could make future cellular immunotherapies less expensive and more accessible to ...

Scripps Research Institute spin-out Calibr's lead candidate combines CLBR001 cells – billed as a "universal" CAR-T because they are not targeted at a specific antigen – and companion antibody ...

Both anti-CD19 PB-CAR-NK and PB-NK cells were co-cultured with CD19+ Nalm6 target cells (E: T = 1:1) in the presence of four factor-specific antibodies or an IgG control, and cytotoxicity was measured ...

Membrane Proteome Array is a technology platform is a cell-based array that contains set of human membrane proteins assembled to determine specificity and preclinical safety of antibodies, CAR-T cell ...

1Department of Hematology, Hemostaseology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany. *Corresponding Author: Maximilian Merz, Department of Hematology, Hemostaseology and ...